Table 2.
X-EFFECTS (♂,♀) | Y-EFFECTS (♂) | |||||
---|---|---|---|---|---|---|
X&Y Dosage Genotypes included in analyses | +0X (XX, XY)
|
+1X (XXY, XXX)
|
+2/3X (XXXY, XXXX, XXXXY, XXXXX)
|
+0Y (XY)
|
+1Y (XYY)
|
|
Estim-VIQ2,4, | N | 52 | 52 | 14 | 27 | 14 |
M | 113.61 | 95.48 | 67.68 | 113.98 | 91.25 | |
SD | 12.50 | 13.25 | 9.07 | 10.77 | 18.36) | |
Estim-PIQ2,4 | N | 52 | 51 | 15 | 27 | 14 |
M | 112.69 | 98.33 | 71 | 114.44 | 102.86 | |
SD | 11.01 | 15.19 | 10.08 | 10.1 | 12.89 | |
Estim-VIQPIQ | N | 52 | 51 | 14 | 27 | 14 |
DIFF.4 | M | 0.91 | −3.19 | −2.68 | −0.46 | −11.61 |
SD | 11.17 | 13.10 | 8.46 | 12.60 | 16.10 | |
STRUCT. | N | 51 | 52 | 21 | 26 | 14 |
LANG.2,4 | M | 106.67 | 90.34 | 73.33 | 106.74 | 85.8 |
SD | 6.22 | 14.06 | 9.61 | 5.83 | 16.04 | |
PRAG. | N | 51 | 52 | 21 | 26 | 14 |
LANG.2,4 | M | 108.26 | 91.15 | 82.2 | 107.02 | 81.07 |
SD | 7.32 | 14.27 | 9.86 | 8.08 | 13.81 | |
SOC. | N | 51 | 52 | 21 | 26 | 14 |
INTER. | M | 2.14 | 1.37 | 8.33 | 0.81 | −4.64 |
DEV. IND.1, 4 | SD | 5.73 | 9.3 | 8.24 | 6.45 | 10.04 |
SRS | N | 50 | 55 | 24 | 26 | 15 |
TOTAL3, 5 | M | 17.83 | 59.07 | 67.99 | 20.24 | 73.13 |
SD | 12.42 | 30.04 | 24.83 | 14.64 | 34.99 |
+0X,+1X<+2/3X;
+0X>+1X>+2/3X;
+0X<+1X, +2/3X;
+0Y>+1Y;
+0Y<+1Y;